H

Health Sciences Centre Winnipeg | Rheumatology Research Department

Research site

(Unclaimed)

Location

MS738-C 820 Sherbrook Street, Winnipeg, Manitoba, Canada

Site insights

Top conditions

Top treatments

Vancomycin

Clindamycin

Cysteamine

Dabigatran

Ceftriaxone

Moxifloxacin

Tocilizumab

Hydrocortisone

TAK-101

Ivermectin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 19 total trials

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

The main aim of the study is to assess if TAK-101 can reduce gluten related symptoms and immune activation in adult participants with celiac disease...

Active, not recruiting

Celiac Disease

Drug: TAK-101

Dietary Supplement: Gluten

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 (FASTEST Part 2)

The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute...

Enrolling

Intracerebral Hemorrhage

Biological: Biological/Vaccine: Placebo

Biological: Recombinant Factor VIIa